Cargando…
A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis
OBJECTIVES: To evaluate pharmacokinetics (PK) of a single dose of an investigational 2% clindamycin phosphate vaginal gel in healthy women by assessment of plasma and vaginal clindamycin concentrations over 7 days, and assess safety. METHODS: Single-centre, Phase 1, single-dose PK study. Blood and v...
Autores principales: | Mauck, Christine K, Atiee, George J, McCulloh, Jennifer, Reynolds, Laurie, Zack, Nadene, Friend, David R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780544/ https://www.ncbi.nlm.nih.gov/pubmed/36418189 http://dx.doi.org/10.1093/jac/dkac386 |
Ejemplares similares
-
A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women
por: Thurman, Andrea, et al.
Publicado: (2023) -
Efficacy of Clindamycin Vaginal Ovule (3-Day Treatment) vs.
Clindamycin Vaginal Cream (7-Day Treatment) in Bacterial Vaginosis
por: Sobel, Jack, et al.
Publicado: (2001) -
Formulation, In Vitro and In Vivo Pharmacokinetics of Anti-HIV
Vaginal Bioadhesive Gel
por: Chatterjee, A, et al.
Publicado: (2011) -
A phase 1/2, open-label, parallel group study to evaluate the preliminary efficacy and usability DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal RinGSM) over 12 weeks in healthy postmenopausal women
por: Thurman, Andrea, et al.
Publicado: (2023) -
Efficacy of Oral Metronidazole with Vaginal Clindamycin or Vaginal Probiotic for Bacterial Vaginosis: Randomised Placebo-Controlled Double-Blind Trial
por: Bradshaw, Catriona S., et al.
Publicado: (2012)